US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...

The consultation on raising the threshold suggests that this change will “ensure that the BIT continues to target those ...

Artificial intelligence (AI) is an increasingly valuable tool in our perpetual quest for the miracles that science regularly ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...

Our round-up of recent biotech financings features a strong first round for City Therapeutics, a new RNAi venture led by ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

Sanofi said in October last year that it was planning to spin off its consumer health business into a separate company before ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

The way forward, then, is to deliver truly personalised medicines and care. For industry, this means developing therapies ...

Eli Lilly has named Thomas Fuchs as its first-ever chief artificial intelligence officer (CAIO), bolstering the digital ...

MERGE announces new Chair. MERGE, a Chicago-based integrated technology and marketing services provider, has a new board ...

Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease ...